2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

被引：663

作者：

Steffel, Jan ^{[1
]}

Collins, Ronan ^{[2
]}

Antz, Matthias ^{[3
]}

Cornu, Pieter ^{[4
]}

Desteghe, Lien ^{[5
,6
,7
]}

Haeusler, Karl Georg ^{[8
]}

Oldgren, Jonas ^{[9
,10
]}

Reinecke, Holger ^{[11
]}

Roldan-Schilling, Vanessa ^{[12
]}

Rowell, Nigel

Sinnaeve, Peter ^{[13
]}

Vanassche, Thomas ^{[13
]}

Potpara, Tatjana ^{[14
]}

Camm, A. John ^{[15
]}

Heidbuechel, Hein ^{[5
,6
,7
]}

Lip, Gregory Y. H. ^{[16
,17
,18
]}

Deneke, Thomas ^{[19
]}

Dagres, Nikolaos ^{[20
]}

Boriani, Giuseppe ^{[21
]}

Chao, Tze-Fan ^{[22
,23
,24
]}

Choi, Eue-Keun ^{[25
]}

Hills, Mellanie True ^{[26
]}

Santos, Itamar de Souza ^{[27
,28
]}

Lane, Deirdre A. ^{[16
,17
,18
]}

Atar, Dan ^{[29
,30
]}

Joung, Boyoung ^{[31
]}

Cole, Oana Maria ^{[16
,17
]}

Field, Mark ^{[16
,17
]}

机构：

[1] Univ Heart Ctr Zurich, Dept Cardiol, Div Electrophysiol, Zurich, Switzerland

[2] Tallaght Univ Hosp, Age Related Hlth Care, Dept Gerontol, Trinity Coll, Dublin, Ireland

[3] Hosp Braunschweig, Dept Electrophysiol, Braunschweig, Germany

[4] Vrije Univ Brussel, Fac Med & Pharm, Res Grp Clin Pharmacol & Clin Pharm, Brussels, Belgium

[5] Antwerp Univ, Cardiol, Antwerp, Belgium

[6] Univ Hosp, Antwerp, Belgium

[7] Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium

[8] Univ Klinikum Wurzburg, Dept Neurol, Wurzburg, Germany

[9] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden

[10] Uppsala Univ, Dept Med Sci, Uppsala, Sweden

[11] Univ Hosp Munster, Dept Cardiol Coronary & Peripheral Vasc Dis 1, Heart Failure, Munster, Germany

[12] Univ Murcia, Murcia, Spain

[13] Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium

[14] Univ Belgrade, Sch Med, Belgrade, Serbia

[15] St Georges Univ, Mol & Clin Sci Inst, Cardiol Clin Acad Grp, London, England

[16] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England

[17] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England

[18] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark

[19] Heart Ctr RHON KLINIKUM, Clin Intervent Electrophysiol, Campus Bad Neustadt, Bad Neustadt an der Saale, Germany

[20] Univ Leipzig, Heart Ctr Leipzig, Dept Electrophysiol, Leipzig, Germany

[21] Univ Modena & Reggio Emilia, Policlin Modena, Cardiol Div, Dept Biomed Metab & Neural Sci, Modena, Italy

[22] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan

[23] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan

[24] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan

[25] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea

[26] StopAfiborg, POB 541, Greenwood, TX 76246 USA

[27] Univ Sao Paulo, Hosp Univ, Ctr Pesquisa Clin & Epidemiol, Sao Paulo, Brazil

[28] Univ Sao Paulo, Fac Med, Dept Clin Med, Sao Paulo, Brazil

[29] Oslo Univ Hosp Ulleval, Dept Cardiol, Oslo, Norway

[30] Univ Oslo, Inst Clin Sci, Oslo, Norway

[31] Yonsei Univ, Cardiol Dept, Coll Med, Seoul, South Korea

来源：

EUROPACE | 2021年 / 23卷 / 10期

关键词：

NOACs; DOACs; apixaban; dabigatran; edoxaban; rivaroxaban; FACTOR-XA INHIBITOR; DIRECT THROMBIN INHIBITOR; PROTHROMBIN COMPLEX CONCENTRATE; CHRONIC KIDNEY-DISEASE; PERCUTANEOUS CORONARY INTERVENTION; TRANSIENT ISCHEMIC ATTACK; DUAL ANTIPLATELET THERAPY; RIVAROXABAN VS. WARFARIN; TOTAL KNEE ARTHROPLASTY; ASSAYS LABORATORY RECOMMENDATIONS;

D O I：

10.1093/europace/euab065

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1612 / 1676

页数：65

共 50 条

[41] Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation
Cha, Myung-Jin
Choi, Eue-Keun
Han, Kyung-Do
Lee, So-Ryoung
Lim, Woo-Hyun
Oh, Seil
Lip, Gregory Y. H.
STROKE, 2017, 48 (11) : 3040 - +
[42] Non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation: safety issues in the elderly
Ajam, Tarek
Cumpian, Tabitha L.
Tilkens, Blair L.
Jahangir, Imaan A.
Frost, Jared
Ceretto, Cheryl
Jahangir, Arshad
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (12) : 1309 - 1327
[43] The role of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation A PRISMA-compliant article
Liu, Xuyang
Huang, Manxiang
Ye, Caisheng
Zeng, Junquan
Zeng, Changai
Ma, Jianyong
MEDICINE, 2020, 99 (27)
[44] Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for atrial fibrillation in Portugal
Costa, Joao
Fiorentino, Francesca
Caldeira, Daniel
Ines, Monica
Pereira, Catarina Lopes
Pinheiro, Luis
Vaz-Carneiro, Antonio
Borges, Margarida
Gouveia, Miguel
REVISTA PORTUGUESA DE CARDIOLOGIA, 2015, 34 (12) : 723 - 737
[45] Which Patients May Benefit from Dose Adjustment of Non-Vitamin K Antagonist Oral Anticoagulants?
Chin, Paul K. L.
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015, 41 (02) : 195 - 207
[46] Atrial fibrillation in dialysis patients: is there a place for non-vitamin K antagonist oral anticoagulants?
Mlodawska, Elzbieta
Lopatowska, Paulina
Malyszko, Jolanta
Banach, Maciej
Sobkowicz, Bozena
Covic, Adrian
Tomaszuk-Kazberuk, Anna
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (09) : 1633 - 1642
[47] The non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with high-normal renal function-A systematic review
Huqi, Alda
Zoccali, Carmine
Giugliano, Robert P.
De Caterina, Raffaele
VASCULAR PHARMACOLOGY, 2022, 147
[48] Factors driving the use of warfarin and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Hu, Mu-Mei
Wang, Jui
Chien, Kuo-Liong
Su, Chin-Ling
Lin, Shin-Yi
Wu, Fe-Lin Lin
Lin, Zhen-Fang
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2017, 116 (04) : 276 - 286
[49] Oral Anticoagulation in Japanese Patients With Atrial Fibrillation - Insight to the Use of Non-Vitamin K Antagonist Oral Anticoagulants
Gomez-Molina, Miriam
Valdes, Mariano
Marin, Francisco
CIRCULATION JOURNAL, 2015, 79 (02) : 292 - 294
[50] Non-Vitamin K Antagonist Oral Anticoagulants: New Choices for Patient Management in Atrial Fibrillation
Saliba, Walid
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2015, 15 (05) : 323 - 335

← 1 2 3 4 5 →